Experimental Mutations in Superoxide Dismutase 1 Provide Insight into Potential Mechanisms Involved in Aberrant Aggregation in Familial Amyotrophic Lateral Sclerosis

Mutations in more than 80 different positions in superoxide dismutase 1 (SOD1) have been associated with amyotrophic lateral sclerosis (fALS). There is substantial evidence that a common consequence of these mutations is to induce the protein to misfold and aggregate. How these mutations perturb native structure to heighten the propensity to misfold and aggregate is unclear. In the present study, we have mutagenized Glu residues at positions 40 and 133 that are involved in stabilizing the β-barrel structure of the native protein and a critical Zn binding domain, respectively, to examine how specific mutations may cause SOD1 misfolding and aggregation. Mutations associated with ALS as well as experimental mutations were introduced into these positions. We used an assay in which mutant SOD1 was fused to yellow fluorescent protein (SOD1:YFP) to visualize the formation of cytosolic inclusions by mutant SOD1. We then used existing structural data on SOD1, to predict how different mutations might alter local 3D conformation. Our findings reveal an association between mutant SOD1 aggregation and amino acid substitutions that are predicted to introduce steric strain, sometimes subtly, in the 3D conformation of the peptide backbone.

[1]  D. Pizzo,et al.  Misfolded SOD1 is not a primary component of sporadic ALS , 2017, Acta Neuropathologica.

[2]  Jacob I. Ayers,et al.  Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models , 2017, Journal of neurochemistry.

[3]  Bryan F. Shaw,et al.  Stochastic Formation of Fibrillar and Amorphous Superoxide Dismutase Oligomers Linked to Amyotrophic Lateral Sclerosis. , 2016, ACS chemical neuroscience.

[4]  T. Saio,et al.  Conformational Disorder of the Most Immature Cu, Zn-Superoxide Dismutase Leading to Amyotrophic Lateral Sclerosis* , 2015, The Journal of Biological Chemistry.

[5]  J. Valentine,et al.  The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu,Zn Superoxide Dismutase (SOD1) Fibrillation* , 2015, The Journal of Biological Chemistry.

[6]  Eamonn F. Healy A model for non-obligate oligomer formation in protein aggregration. , 2015, Biochemical and biophysical research communications.

[7]  Bryan F. Shaw,et al.  Arresting amyloid with coulomb's law: acetylation of ALS-linked SOD1 by aspirin impedes aggregation. , 2015, Biophysical journal.

[8]  John A Tainer,et al.  Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes , 2014, Proceedings of the National Academy of Sciences.

[9]  J. Attems,et al.  Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot , 2014, Acta neuropathologica communications.

[10]  D. Borchelt,et al.  Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases , 2014, Acta neuropathologica communications.

[11]  C. Angelini,et al.  Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants , 2014, Neurobiology of Aging.

[12]  A. Hill,et al.  Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms , 2014, Proceedings of the National Academy of Sciences.

[13]  H. Kusaka,et al.  An autopsy case of sporadic amyotrophic lateral sclerosis associated with the I113T SOD1 mutation , 2014, Neuropathology (Kyoto. 1993).

[14]  Jacob I. Ayers,et al.  Distinctive features of the D101N and D101G variants of superoxide dismutase 1; two mutations that produce rapidly progressing motor neuron disease , 2014, Journal of neurochemistry.

[15]  E. L. Guenther,et al.  Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS , 2013, Proceedings of the National Academy of Sciences.

[16]  L. Piedrafita,et al.  Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis. , 2013, Journal of neuropathology and experimental neurology.

[17]  D. Borchelt,et al.  Role of Disulfide Cross-Linking of Mutant SOD1 in the Formation of Inclusion-Body-Like Structures , 2012, PloS one.

[18]  A. Nakamura,et al.  Distinctive clinicopathological features of 2 large families with amyotrophic lateral sclerosis having L106V mutation in SOD1 gene , 2012, Journal of the Neurological Sciences.

[19]  M. Gearing,et al.  Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS , 2012, Proceedings of the National Academy of Sciences.

[20]  D. Borchelt,et al.  Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states , 2011, Molecular Neurodegeneration.

[21]  S. Dunn,et al.  Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS , 2011, Proceedings of the National Academy of Sciences.

[22]  D. Borchelt,et al.  Copper and Zinc Metallation Status of Copper-Zinc Superoxide Dismutase from Amyotrophic Lateral Sclerosis Transgenic Mice* , 2010, The Journal of Biological Chemistry.

[23]  J. Rumfeldt,et al.  Nonamyloid Aggregates Arising from Mature Copper/Zinc Superoxide Dismutases Resemble Those Observed in Amyotrophic Lateral Sclerosis* , 2010, The Journal of Biological Chemistry.

[24]  Jeffery N Agar,et al.  Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS , 2010, Nature Neuroscience.

[25]  Johan Jacobsson,et al.  Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients , 2010, PloS one.

[26]  D. Borchelt,et al.  Copper–Zinc Superoxide Dismutase, Its Copper Chaperone, and Familial Amyotrophic Lateral Sclerosis , 2010 .

[27]  A. Bertolotti,et al.  Exposure of Hydrophobic Surfaces Initiates Aggregation of Diverse ALS-Causing Superoxide Dismutase-1 Mutants , 2010, Journal of molecular biology.

[28]  N. Nukina,et al.  Mutation-dependent Polymorphism of Cu,Zn-Superoxide Dismutase Aggregates in the Familial Form of Amyotrophic Lateral Sclerosis* , 2010, The Journal of Biological Chemistry.

[29]  P. Andersen,et al.  SOD1 Mutations Targeting Surface Hydrogen Bonds Promote Amyotrophic Lateral Sclerosis without Reducing Apo-state Stability* , 2010, The Journal of Biological Chemistry.

[30]  S. Croul,et al.  Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form , 2010, Acta Neuropathologica.

[31]  H. Neumann,et al.  Wild-type Cu/Zn superoxide dismutase (SOD1) does not facilitate, but impedes the formation of protein aggregates of amyotrophic lateral sclerosis causing mutant SOD1 , 2009, Neurobiology of Disease.

[32]  D. Borchelt,et al.  Immature Copper-Zinc Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis , 2009, Experimental biology and medicine.

[33]  D. Borchelt,et al.  Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease , 2009, Human molecular genetics.

[34]  D. Borchelt,et al.  Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS , 2009, Proceedings of the National Academy of Sciences.

[35]  J. Yates,et al.  Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS , 2009, Proceedings of the National Academy of Sciences.

[36]  Julian P. Whitelegge,et al.  Initiation and elongation in fibrillation of ALS-linked superoxide dismutase , 2008, Proceedings of the National Academy of Sciences.

[37]  I. Tooyama,et al.  The endoplasmic reticulum‐Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  D. Borchelt,et al.  A Limited Role for Disulfide Cross-linking in the Aggregation of Mutant SOD1 Linked to Familial Amyotrophic Lateral Sclerosis* , 2008, Journal of Biological Chemistry.

[39]  K. Oyanagi,et al.  Familial amyotrophic lateral sclerosis with Gly93Ser mutation in Cu/Zn superoxide dismutase: A clinical and neuropathological study , 2008, Journal of the Neurological Sciences.

[40]  P. Andersen,et al.  Inclusions of amyotrophic lateral sclerosis–linked superoxide dismutase in ventral horns, liver, and kidney , 2008, Annals of neurology.

[41]  I. Bertini,et al.  SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization , 2008, PloS one.

[42]  R. Strange,et al.  Molecular dynamics using atomic-resolution structure reveal structural fluctuations that may lead to polymerization of human Cu–Zn superoxide dismutase , 2007, Proceedings of the National Academy of Sciences.

[43]  R. Kopito,et al.  Impaired post‐translational folding of familial ALS‐linked Cu, Zn superoxide dismutase mutants , 2007, The EMBO journal.

[44]  P. Andersen,et al.  Motor Neuron Disease in Mice Expressing the Wild Type-Like D90A Mutant Superoxide Dismutase-1 , 2006, Journal of neuropathology and experimental neurology.

[45]  X. Yao,et al.  SUMO-1 modification increases human SOD1 stability and aggregation , 2006, Neuroscience Research.

[46]  Fujian Zhang,et al.  Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death. , 2006, Biochimica et biophysica acta.

[47]  P. Andersen,et al.  Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. , 2006, Brain : a journal of neurology.

[48]  D. Borchelt,et al.  Mapping superoxide dismutase 1 domains of non‐native interaction: roles of intra‐ and intermolecular disulfide bonding in aggregation , 2006, Journal of neurochemistry.

[49]  R. Morimoto,et al.  Structural properties and neuronal toxicity of amyotrophic lateral sclerosis–associated Cu/Zn superoxide dismutase 1 aggregates , 2005, The Journal of cell biology.

[50]  D. Borchelt,et al.  Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: alphaB-crystallin modulates aggregation. , 2005, Human molecular genetics.

[51]  Bryan F. Shaw,et al.  Destabilization of apoprotein is insufficient to explain Cu,Zn-superoxide dismutase-linked ALS pathogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  T. O’Halloran,et al.  Amyotrophic Lateral Sclerosis Mutations Have the Greatest Destabilizing Effect on the Apo- and Reduced Form of SOD1, Leading to Unfolding and Oxidative Aggregation* , 2005, Journal of Biological Chemistry.

[53]  A. Hill,et al.  Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis , 2005, The Journal of Neuroscience.

[54]  Borries Demeler,et al.  Dissociation of Human Copper-Zinc Superoxide Dismutase Dimers Using Chaotrope and Reductant , 2004, Journal of Biological Chemistry.

[55]  I. Bertini,et al.  The Unusually Stable Quaternary Structure of Human Cu,Zn-Superoxide Dismutase 1 Is Controlled by Both Metal Occupancy and Disulfide Status* , 2004, Journal of Biological Chemistry.

[56]  A. Holmgren,et al.  Folding of human superoxide dismutase: disulfide reduction prevents dimerization and produces marginally stable monomers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Yazawa,et al.  Familial amyotrophic lateral sclerosis with His46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusions , 2004, Journal of the Neurological Sciences.

[58]  S. Tsuji,et al.  Familial amyotrophic lateral sclerosis with bulbar onset and a novel Asp101Tyr Cu/Zn superoxide dismutase gene mutation , 2004, Acta Neuropathologica.

[59]  Timothy J Mitchison,et al.  A Novel Action of Histone Deacetylase Inhibitors in a Protein Aggresome Disease Model , 2004, Current Biology.

[60]  D. Borchelt,et al.  Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. , 2003, Human molecular genetics.

[61]  John A Tainer,et al.  ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. , 2003, Journal of molecular biology.

[62]  Jennifer Stine Elam,et al.  Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS , 2003, Nature Structural Biology.

[63]  A. Chakrabartty,et al.  Oxidation-induced Misfolding and Aggregation of Superoxide Dismutase and Its Implications for Amyotrophic Lateral Sclerosis* , 2002, The Journal of Biological Chemistry.

[64]  Robert H. Brown,et al.  Decreased Metallation and Activity in Subsets of Mutant Superoxide Dismutases Associated with Familial Amyotrophic Lateral Sclerosis* 210 , 2002, The Journal of Biological Chemistry.

[65]  D. Borchelt,et al.  High Molecular Weight Complexes of Mutant Superoxide Dismutase 1: Age-Dependent and Tissue-Specific Accumulation , 2002, Neurobiology of Disease.

[66]  S. Sakoda,et al.  Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation , 2001, Acta Neuropathologica.

[67]  M. Nishibori,et al.  Familial amyotrophic lateral sclerosis with a novel Leu126Ser mutation in the copper/zinc superoxide dismutase gene showing mild clinical features and lewy body-like hyaline inclusions. , 2001, Archives of neurology.

[68]  S. Minotti,et al.  Mutant Cu/Zn-Superoxide Dismutase Proteins Have Altered Solubility and Interact with Heat Shock/Stress Proteins in Models of Amyotrophic Lateral Sclerosis* , 2001, The Journal of Biological Chemistry.

[69]  M. Gurney,et al.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[70]  S. Tsuji,et al.  Accumulation of neurofilaments and SOD1-immunoreactive products in a patient with familial amyotrophic lateral sclerosis with I113T SOD1 mutation. , 1999, Archives of neurology.

[71]  D. Borchelt,et al.  Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. , 1999, Human molecular genetics.

[72]  D. Eisenberg,et al.  A structure-based mechanism for copper-zinc superoxide dismutase. , 1999, Biochemistry.

[73]  S. Tsuji,et al.  Familial amyotrophic lateral sclerosis with widespread vacuolation and hyaline inclusions , 1998, Neurology.

[74]  Matteo Pellegrini,et al.  Subunit asymmetry in the three‐dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis , 1998, Protein science : a publication of the Protein Society.

[75]  J. Powell,et al.  Familial amyotrophic lateral sclerosis , 1997, Neurology.

[76]  W. Hung,et al.  Intense Superoxide Dismutase‐1 Immunoreactivity in Intracytoplasmic Hyaline Inclusions of Familial Amyotrophic Lateral Sclerosis with Posterior Column Involvement , 1996, Journal of neuropathology and experimental neurology.

[77]  D. Eisenberg,et al.  Unusual trigonal-planar copper configuration revealed in the atomic structure of yeast copper-zinc superoxide dismutase. , 1996, Biochemistry.

[78]  D. Bredesen,et al.  Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.

[79]  D. Borchelt,et al.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.

[80]  J. Valentine,et al.  Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[81]  D. Borchelt,et al.  Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[82]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[83]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[84]  J. Tainer,et al.  Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[85]  S. Nagata,et al.  pEF-BOS, a powerful mammalian expression vector. , 1990, Nucleic acids research.

[86]  I. Fridovich,et al.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.

[87]  P. Andersen,et al.  Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. , 2013, Human molecular genetics.

[88]  Taewook Kang,et al.  Lipid molecules induce the cytotoxic aggregation of Cu/Zn superoxide dismutase with structurally disordered regions. , 2011, Biochimica et biophysica acta.

[89]  P. Andersen,et al.  Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. , 2004, Brain : a journal of neurology.

[90]  N. Shibata,et al.  Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. , 1996, Developmental neuroscience.

[91]  I. Fridovich,et al.  Superoxide dismutases. , 1975, Annual review of biochemistry.